| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Smoking Cessation | 23 | 2017 | 550 | 3.280 |
Why?
|
| Postmenopause | 60 | 2019 | 237 | 3.020 |
Why?
|
| Students, Medical | 10 | 2023 | 261 | 2.930 |
Why?
|
| Women's Health | 43 | 2022 | 370 | 2.670 |
Why?
|
| Counseling | 18 | 2022 | 362 | 2.530 |
Why?
|
| Tobacco Use Disorder | 13 | 2016 | 246 | 2.370 |
Why?
|
| Education, Medical | 6 | 2023 | 181 | 2.270 |
Why?
|
| Clinical Competence | 16 | 2022 | 725 | 1.920 |
Why?
|
| Smoking | 24 | 2017 | 866 | 1.700 |
Why?
|
| Estrogen Replacement Therapy | 22 | 2018 | 81 | 1.410 |
Why?
|
| Education, Medical, Undergraduate | 6 | 2016 | 157 | 1.410 |
Why?
|
| Cardiovascular Diseases | 18 | 2022 | 834 | 1.280 |
Why?
|
| Body Weight Maintenance | 2 | 2021 | 14 | 1.260 |
Why?
|
| Estrogens, Conjugated (USP) | 16 | 2013 | 22 | 1.190 |
Why?
|
| Health Promotion | 7 | 2013 | 497 | 1.130 |
Why?
|
| Curriculum | 9 | 2021 | 596 | 1.060 |
Why?
|
| Health Behavior | 11 | 2017 | 469 | 0.980 |
Why?
|
| Schools, Medical | 5 | 2021 | 145 | 0.940 |
Why?
|
| Humans | 160 | 2023 | 63309 | 0.920 |
Why?
|
| Behavioral Medicine | 4 | 2021 | 37 | 0.900 |
Why?
|
| Breast Neoplasms | 20 | 2018 | 1195 | 0.880 |
Why?
|
| Female | 124 | 2022 | 32806 | 0.810 |
Why?
|
| Proportional Hazards Models | 38 | 2022 | 729 | 0.800 |
Why?
|
| Self Efficacy | 5 | 2017 | 201 | 0.790 |
Why?
|
| Coronary Disease | 14 | 2016 | 246 | 0.790 |
Why?
|
| Aged | 92 | 2019 | 14396 | 0.780 |
Why?
|
| Follow-Up Studies | 36 | 2019 | 2457 | 0.780 |
Why?
|
| United States | 53 | 2019 | 7827 | 0.760 |
Why?
|
| Middle Aged | 91 | 2019 | 17558 | 0.760 |
Why?
|
| Risk Factors | 54 | 2022 | 5345 | 0.750 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2021 | 695 | 0.750 |
Why?
|
| Medroxyprogesterone Acetate | 10 | 2013 | 12 | 0.750 |
Why?
|
| Menopause | 5 | 2018 | 258 | 0.730 |
Why?
|
| Health Status | 10 | 2016 | 435 | 0.720 |
Why?
|
| Diet | 10 | 2022 | 524 | 0.720 |
Why?
|
| Nutritionists | 1 | 2021 | 3 | 0.710 |
Why?
|
| Counselors | 1 | 2021 | 5 | 0.710 |
Why?
|
| Depression | 13 | 2015 | 892 | 0.700 |
Why?
|
| Alcohol Drinking | 7 | 2015 | 314 | 0.690 |
Why?
|
| Estrogens | 10 | 2018 | 116 | 0.690 |
Why?
|
| Inflammation | 10 | 2022 | 1145 | 0.660 |
Why?
|
| Quality of Life | 11 | 2016 | 1225 | 0.610 |
Why?
|
| Incidence | 31 | 2019 | 1376 | 0.600 |
Why?
|
| Physician-Patient Relations | 6 | 2009 | 419 | 0.590 |
Why?
|
| Research Design | 4 | 2017 | 573 | 0.560 |
Why?
|
| Diabetes Mellitus | 10 | 2016 | 539 | 0.550 |
Why?
|
| Progestins | 6 | 2018 | 29 | 0.550 |
Why?
|
| Prospective Studies | 30 | 2019 | 3285 | 0.550 |
Why?
|
| Cross-Sectional Studies | 16 | 2021 | 2569 | 0.540 |
Why?
|
| Community Health Centers | 4 | 2006 | 92 | 0.540 |
Why?
|
| Hot Flashes | 3 | 2013 | 100 | 0.460 |
Why?
|
| Poverty | 4 | 2005 | 296 | 0.460 |
Why?
|
| Internship and Residency | 1 | 2022 | 800 | 0.460 |
Why?
|
| Cognition Disorders | 8 | 2016 | 217 | 0.450 |
Why?
|
| Antidepressive Agents | 7 | 2013 | 225 | 0.450 |
Why?
|
| Colorectal Neoplasms | 9 | 2019 | 274 | 0.450 |
Why?
|
| Randomized Controlled Trials as Topic | 11 | 2018 | 769 | 0.440 |
Why?
|
| Primary Prevention | 6 | 2012 | 136 | 0.430 |
Why?
|
| Checklist | 1 | 2015 | 73 | 0.430 |
Why?
|
| Cognition | 8 | 2016 | 483 | 0.430 |
Why?
|
| Clinical Clerkship | 4 | 2016 | 91 | 0.420 |
Why?
|
| Equol | 1 | 2013 | 5 | 0.420 |
Why?
|
| Phytoestrogens | 1 | 2013 | 9 | 0.420 |
Why?
|
| Evidence-Based Medicine | 6 | 2009 | 462 | 0.420 |
Why?
|
| Social Support | 4 | 2016 | 371 | 0.420 |
Why?
|
| Isoflavones | 1 | 2013 | 17 | 0.420 |
Why?
|
| Risk Assessment | 15 | 2018 | 2077 | 0.410 |
Why?
|
| Feeding Behavior | 7 | 2018 | 259 | 0.400 |
Why?
|
| Spirituality | 1 | 2013 | 39 | 0.400 |
Why?
|
| Surveys and Questionnaires | 19 | 2019 | 2674 | 0.390 |
Why?
|
| Neoplasms | 5 | 2022 | 1361 | 0.380 |
Why?
|
| Diet, Fat-Restricted | 6 | 2010 | 33 | 0.380 |
Why?
|
| Geriatric Assessment | 5 | 2016 | 163 | 0.370 |
Why?
|
| Social Facilitation | 1 | 2011 | 4 | 0.370 |
Why?
|
| Patient-Centered Care | 3 | 2012 | 254 | 0.360 |
Why?
|
| Guideline Adherence | 3 | 2011 | 305 | 0.360 |
Why?
|
| Personality | 1 | 2011 | 29 | 0.350 |
Why?
|
| American Heart Association | 1 | 2011 | 126 | 0.340 |
Why?
|
| Financing, Government | 2 | 2011 | 31 | 0.340 |
Why?
|
| Risk | 14 | 2015 | 377 | 0.340 |
Why?
|
| Weight Loss | 2 | 2011 | 272 | 0.330 |
Why?
|
| Self Report | 6 | 2016 | 375 | 0.320 |
Why?
|
| Mortality | 1 | 2011 | 160 | 0.320 |
Why?
|
| Fractures, Bone | 5 | 2019 | 143 | 0.320 |
Why?
|
| Adult | 25 | 2021 | 16794 | 0.320 |
Why?
|
| Directive Counseling | 1 | 2009 | 39 | 0.310 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2016 | 216 | 0.310 |
Why?
|
| Accidental Falls | 4 | 2016 | 127 | 0.310 |
Why?
|
| Socioeconomic Factors | 6 | 2016 | 777 | 0.300 |
Why?
|
| Postpartum Period | 3 | 2005 | 195 | 0.300 |
Why?
|
| Hormone Replacement Therapy | 4 | 2013 | 29 | 0.300 |
Why?
|
| Psychotherapy | 1 | 2009 | 97 | 0.300 |
Why?
|
| Obesity | 7 | 2021 | 1232 | 0.300 |
Why?
|
| Overweight | 4 | 2021 | 250 | 0.290 |
Why?
|
| Smoking Prevention | 6 | 2017 | 162 | 0.280 |
Why?
|
| Health Personnel | 2 | 2021 | 367 | 0.280 |
Why?
|
| Body Weight | 4 | 2018 | 377 | 0.280 |
Why?
|
| Exercise | 8 | 2019 | 940 | 0.280 |
Why?
|
| Longitudinal Studies | 10 | 2017 | 1255 | 0.270 |
Why?
|
| Biomarkers | 8 | 2018 | 1397 | 0.270 |
Why?
|
| Risk Reduction Behavior | 3 | 2013 | 121 | 0.270 |
Why?
|
| Community Health Planning | 1 | 2007 | 16 | 0.270 |
Why?
|
| Preventive Medicine | 1 | 2007 | 24 | 0.270 |
Why?
|
| Educational Measurement | 2 | 2013 | 217 | 0.260 |
Why?
|
| Vitamin D | 4 | 2011 | 140 | 0.260 |
Why?
|
| Weight Gain | 3 | 2013 | 169 | 0.260 |
Why?
|
| Aging | 8 | 2018 | 745 | 0.260 |
Why?
|
| Pregnancy Complications | 4 | 2004 | 377 | 0.260 |
Why?
|
| Health Knowledge, Attitudes, Practice | 7 | 2015 | 762 | 0.250 |
Why?
|
| Public Health Administration | 1 | 2006 | 22 | 0.250 |
Why?
|
| Practice Guidelines as Topic | 5 | 2011 | 734 | 0.250 |
Why?
|
| Disability Evaluation | 3 | 2016 | 217 | 0.250 |
Why?
|
| Life Style | 6 | 2014 | 311 | 0.250 |
Why?
|
| Motor Activity | 4 | 2014 | 346 | 0.250 |
Why?
|
| Melatonin | 2 | 2018 | 66 | 0.250 |
Why?
|
| Preceptorship | 2 | 2018 | 41 | 0.250 |
Why?
|
| Public Policy | 1 | 2006 | 41 | 0.250 |
Why?
|
| Community Health Services | 1 | 2007 | 128 | 0.240 |
Why?
|
| Health Resources | 1 | 2006 | 94 | 0.240 |
Why?
|
| Science | 1 | 2006 | 34 | 0.240 |
Why?
|
| Logistic Models | 9 | 2015 | 1274 | 0.230 |
Why?
|
| Age Factors | 7 | 2015 | 1558 | 0.230 |
Why?
|
| Sexual Behavior | 3 | 2018 | 194 | 0.220 |
Why?
|
| Massachusetts | 11 | 2018 | 2076 | 0.220 |
Why?
|
| Communication | 3 | 2022 | 571 | 0.220 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2005 | 123 | 0.210 |
Why?
|
| Interviews as Topic | 5 | 2011 | 510 | 0.210 |
Why?
|
| Learning | 2 | 2022 | 182 | 0.210 |
Why?
|
| Education, Medical, Continuing | 2 | 2003 | 96 | 0.210 |
Why?
|
| Schools | 2 | 2023 | 166 | 0.200 |
Why?
|
| Body Mass Index | 8 | 2017 | 864 | 0.200 |
Why?
|
| Puerperal Disorders | 1 | 2002 | 15 | 0.200 |
Why?
|
| Temperance | 1 | 2002 | 13 | 0.200 |
Why?
|
| Stroke | 10 | 2015 | 1192 | 0.200 |
Why?
|
| Regression Analysis | 2 | 2015 | 498 | 0.190 |
Why?
|
| Residence Characteristics | 3 | 2013 | 220 | 0.190 |
Why?
|
| Time Factors | 10 | 2018 | 3763 | 0.190 |
Why?
|
| Teaching | 1 | 2023 | 159 | 0.190 |
Why?
|
| Male | 25 | 2015 | 29834 | 0.190 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2013 | 860 | 0.190 |
Why?
|
| Odds Ratio | 7 | 2014 | 768 | 0.180 |
Why?
|
| Demography | 2 | 2012 | 173 | 0.180 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2013 | 46 | 0.180 |
Why?
|
| Energy Intake | 4 | 2011 | 171 | 0.180 |
Why?
|
| Cohort Studies | 13 | 2015 | 2569 | 0.180 |
Why?
|
| Stillbirth | 2 | 2014 | 17 | 0.170 |
Why?
|
| Hysterectomy | 5 | 2012 | 69 | 0.170 |
Why?
|
| Cause of Death | 4 | 2018 | 221 | 0.170 |
Why?
|
| Health Status Disparities | 2 | 2013 | 146 | 0.170 |
Why?
|
| Prevalence | 8 | 2018 | 1378 | 0.160 |
Why?
|
| Dietary Supplements | 2 | 2013 | 234 | 0.160 |
Why?
|
| Progesterone Congeners | 3 | 2006 | 6 | 0.160 |
Why?
|
| Dietary Fats | 3 | 2012 | 174 | 0.160 |
Why?
|
| Pregnancy | 7 | 2014 | 2333 | 0.160 |
Why?
|
| Health Surveys | 7 | 2016 | 313 | 0.160 |
Why?
|
| Nurse Practitioners | 2 | 2005 | 117 | 0.160 |
Why?
|
| Peripheral Arterial Disease | 2 | 2012 | 172 | 0.160 |
Why?
|
| Internal Medicine | 2 | 2005 | 160 | 0.160 |
Why?
|
| Patient Care Team | 2 | 2021 | 337 | 0.160 |
Why?
|
| Hip Fractures | 5 | 2019 | 77 | 0.150 |
Why?
|
| Hypertension | 5 | 2018 | 585 | 0.150 |
Why?
|
| Vasomotor System | 2 | 2011 | 22 | 0.150 |
Why?
|
| C-Reactive Protein | 4 | 2016 | 166 | 0.150 |
Why?
|
| Cholesterol, LDL | 4 | 2012 | 103 | 0.150 |
Why?
|
| Staff Development | 1 | 2019 | 57 | 0.150 |
Why?
|
| Community Networks | 2 | 2011 | 31 | 0.150 |
Why?
|
| Organizational Case Studies | 2 | 2011 | 39 | 0.140 |
Why?
|
| Young Adult | 4 | 2018 | 4687 | 0.140 |
Why?
|
| Program Development | 2 | 2011 | 207 | 0.140 |
Why?
|
| Drug Administration Schedule | 3 | 2013 | 298 | 0.140 |
Why?
|
| Treatment Outcome | 8 | 2013 | 5660 | 0.140 |
Why?
|
| Retirement | 1 | 2018 | 18 | 0.140 |
Why?
|
| Health Facilities | 1 | 2018 | 43 | 0.140 |
Why?
|
| Survivors | 2 | 2016 | 171 | 0.140 |
Why?
|
| Patient Education as Topic | 5 | 2012 | 474 | 0.140 |
Why?
|
| Depressive Disorder | 2 | 2012 | 284 | 0.140 |
Why?
|
| Patients | 2 | 2012 | 113 | 0.140 |
Why?
|
| Double-Blind Method | 9 | 2012 | 738 | 0.140 |
Why?
|
| Lung Neoplasms | 3 | 2010 | 668 | 0.140 |
Why?
|
| Confidence Intervals | 3 | 2013 | 240 | 0.130 |
Why?
|
| Models, Educational | 3 | 2014 | 67 | 0.130 |
Why?
|
| Health Care Surveys | 4 | 2013 | 286 | 0.130 |
Why?
|
| Chest Pain | 2 | 2008 | 84 | 0.130 |
Why?
|
| Dementia | 3 | 2012 | 260 | 0.130 |
Why?
|
| Leadership | 1 | 2019 | 206 | 0.130 |
Why?
|
| Personal Autonomy | 3 | 2007 | 68 | 0.130 |
Why?
|
| Alcoholism | 1 | 1999 | 318 | 0.130 |
Why?
|
| Calcium Carbonate | 2 | 2006 | 4 | 0.130 |
Why?
|
| Health Services Research | 2 | 2009 | 271 | 0.120 |
Why?
|
| Attitude to Health | 2 | 2017 | 289 | 0.120 |
Why?
|
| Motivation | 2 | 2014 | 284 | 0.120 |
Why?
|
| Smokers | 1 | 2017 | 119 | 0.120 |
Why?
|
| Faculty, Medical | 1 | 2018 | 198 | 0.120 |
Why?
|
| Mobility Limitation | 1 | 2016 | 49 | 0.120 |
Why?
|
| Program Evaluation | 4 | 2006 | 487 | 0.120 |
Why?
|
| Diet Records | 3 | 2017 | 34 | 0.120 |
Why?
|
| Patient Compliance | 4 | 2007 | 360 | 0.120 |
Why?
|
| Blood Pressure | 1 | 2018 | 509 | 0.120 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2011 | 390 | 0.120 |
Why?
|
| Nutritional Sciences | 2 | 2007 | 32 | 0.120 |
Why?
|
| Computer-Assisted Instruction | 1 | 2016 | 80 | 0.120 |
Why?
|
| Analysis of Variance | 5 | 2012 | 608 | 0.110 |
Why?
|
| Comorbidity | 5 | 2019 | 1123 | 0.110 |
Why?
|
| Interleukin-6 | 3 | 2015 | 321 | 0.110 |
Why?
|
| Talc | 1 | 2014 | 5 | 0.110 |
Why?
|
| Anticholesteremic Agents | 2 | 2012 | 35 | 0.110 |
Why?
|
| Linear Models | 6 | 2015 | 409 | 0.110 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2006 | 712 | 0.110 |
Why?
|
| Perineum | 1 | 2014 | 19 | 0.110 |
Why?
|
| Bone Density | 2 | 2013 | 134 | 0.110 |
Why?
|
| Primary Health Care | 4 | 2005 | 690 | 0.110 |
Why?
|
| Video Recording | 1 | 2015 | 135 | 0.110 |
Why?
|
| Tobacco Use Cessation | 2 | 2005 | 29 | 0.110 |
Why?
|
| Pregnancy, Ectopic | 1 | 2014 | 10 | 0.110 |
Why?
|
| Walking | 2 | 2014 | 238 | 0.110 |
Why?
|
| Aged, 80 and over | 9 | 2018 | 5449 | 0.110 |
Why?
|
| Frail Elderly | 2 | 2012 | 109 | 0.110 |
Why?
|
| Abortion, Spontaneous | 1 | 2014 | 31 | 0.110 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2014 | 57 | 0.100 |
Why?
|
| Boston | 2 | 2005 | 252 | 0.100 |
Why?
|
| Dietary Proteins | 2 | 2011 | 42 | 0.100 |
Why?
|
| Rectal Neoplasms | 1 | 2014 | 104 | 0.100 |
Why?
|
| Data Collection | 3 | 2011 | 383 | 0.100 |
Why?
|
| Laxatives | 1 | 2013 | 3 | 0.100 |
Why?
|
| Psychophysiology | 1 | 2013 | 7 | 0.100 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 2 | 2015 | 30 | 0.100 |
Why?
|
| Ovarian Neoplasms | 1 | 2014 | 148 | 0.100 |
Why?
|
| Statistics as Topic | 2 | 2011 | 147 | 0.100 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2013 | 48 | 0.100 |
Why?
|
| Snoring | 1 | 2012 | 8 | 0.100 |
Why?
|
| Environment Design | 1 | 2013 | 22 | 0.100 |
Why?
|
| Colonic Neoplasms | 1 | 2014 | 220 | 0.100 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2013 | 47 | 0.100 |
Why?
|
| Preventive Health Services | 3 | 2009 | 75 | 0.100 |
Why?
|
| Calcium | 3 | 2012 | 573 | 0.100 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2013 | 26 | 0.100 |
Why?
|
| Observation | 1 | 2012 | 30 | 0.100 |
Why?
|
| Meditation | 1 | 2013 | 56 | 0.100 |
Why?
|
| Coronary Artery Disease | 1 | 2016 | 310 | 0.100 |
Why?
|
| Climacteric | 1 | 2012 | 4 | 0.090 |
Why?
|
| Religion and Psychology | 1 | 2012 | 11 | 0.090 |
Why?
|
| Cholecalciferol | 1 | 2012 | 28 | 0.090 |
Why?
|
| Mental Disorders | 2 | 2010 | 792 | 0.090 |
Why?
|
| Pilot Projects | 2 | 2013 | 1007 | 0.090 |
Why?
|
| Vitamins | 1 | 2012 | 80 | 0.090 |
Why?
|
| Cardiology | 1 | 2013 | 167 | 0.090 |
Why?
|
| Anxiety | 2 | 2005 | 423 | 0.090 |
Why?
|
| Constipation | 1 | 2011 | 15 | 0.090 |
Why?
|
| Educational Status | 5 | 2014 | 275 | 0.090 |
Why?
|
| Risk-Taking | 2 | 2009 | 162 | 0.090 |
Why?
|
| Dysthymic Disorder | 1 | 2011 | 8 | 0.090 |
Why?
|
| Attention | 1 | 2012 | 148 | 0.090 |
Why?
|
| Dementia, Vascular | 1 | 2011 | 11 | 0.090 |
Why?
|
| Heart Diseases | 2 | 2015 | 217 | 0.090 |
Why?
|
| Activities of Daily Living | 1 | 2013 | 291 | 0.090 |
Why?
|
| Hypercholesterolemia | 1 | 2011 | 70 | 0.090 |
Why?
|
| Prenatal Care | 2 | 2002 | 170 | 0.090 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2011 | 46 | 0.090 |
Why?
|
| Urinary Incontinence | 1 | 2011 | 44 | 0.080 |
Why?
|
| Urban Population | 1 | 2011 | 193 | 0.080 |
Why?
|
| Metabolic Diseases | 1 | 2011 | 58 | 0.080 |
Why?
|
| Sleep | 1 | 2013 | 224 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2011 | 2167 | 0.080 |
Why?
|
| Dietary Carbohydrates | 1 | 2010 | 61 | 0.080 |
Why?
|
| Recurrence | 1 | 2011 | 641 | 0.080 |
Why?
|
| Multivariate Analysis | 3 | 2014 | 936 | 0.080 |
Why?
|
| Lipoproteins | 1 | 2010 | 83 | 0.080 |
Why?
|
| Mammography | 2 | 2009 | 280 | 0.080 |
Why?
|
| Needs Assessment | 2 | 2018 | 198 | 0.080 |
Why?
|
| Health Care Costs | 1 | 2011 | 210 | 0.080 |
Why?
|
| Life Change Events | 1 | 2009 | 66 | 0.070 |
Why?
|
| Electronic Health Records | 1 | 2012 | 360 | 0.070 |
Why?
|
| Stress, Psychological | 2 | 2011 | 469 | 0.070 |
Why?
|
| Triglycerides | 1 | 2010 | 244 | 0.070 |
Why?
|
| Nutrition Assessment | 1 | 2008 | 28 | 0.070 |
Why?
|
| Depressive Disorder, Major | 1 | 2011 | 255 | 0.070 |
Why?
|
| Advisory Committees | 1 | 2009 | 112 | 0.070 |
Why?
|
| Pain | 2 | 2015 | 406 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 3 | 2018 | 278 | 0.070 |
Why?
|
| Drug Combinations | 4 | 2010 | 165 | 0.070 |
Why?
|
| Dietary Fiber | 1 | 2008 | 75 | 0.070 |
Why?
|
| Cognitive Dysfunction | 1 | 2012 | 331 | 0.070 |
Why?
|
| Clinical Trials as Topic | 2 | 2012 | 455 | 0.070 |
Why?
|
| United States Public Health Service | 1 | 2007 | 1 | 0.070 |
Why?
|
| Myocardial Infarction | 3 | 2011 | 913 | 0.070 |
Why?
|
| Ecology | 1 | 2007 | 14 | 0.070 |
Why?
|
| Heart Rate | 1 | 2009 | 322 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 659 | 0.070 |
Why?
|
| Online Systems | 1 | 2007 | 20 | 0.070 |
Why?
|
| Case-Control Studies | 3 | 2018 | 1120 | 0.060 |
Why?
|
| Congenital Abnormalities | 1 | 2006 | 26 | 0.060 |
Why?
|
| Behavior, Addictive | 1 | 2007 | 73 | 0.060 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2006 | 29 | 0.060 |
Why?
|
| Calcinosis | 1 | 2007 | 84 | 0.060 |
Why?
|
| Planning Techniques | 1 | 2006 | 14 | 0.060 |
Why?
|
| Community Mental Health Centers | 1 | 2006 | 18 | 0.060 |
Why?
|
| Organizational Objectives | 1 | 2006 | 59 | 0.060 |
Why?
|
| Competency-Based Education | 2 | 2005 | 30 | 0.060 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2006 | 66 | 0.060 |
Why?
|
| Diffusion of Innovation | 1 | 2006 | 58 | 0.060 |
Why?
|
| Pulmonary Embolism | 4 | 2013 | 172 | 0.060 |
Why?
|
| Substance Abuse Treatment Centers | 1 | 2006 | 104 | 0.060 |
Why?
|
| Syndrome | 2 | 2018 | 180 | 0.060 |
Why?
|
| Chi-Square Distribution | 2 | 2005 | 417 | 0.060 |
Why?
|
| Students | 1 | 2007 | 217 | 0.060 |
Why?
|
| Affect | 1 | 2006 | 125 | 0.060 |
Why?
|
| Survival Analysis | 3 | 2019 | 581 | 0.060 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2009 | 360 | 0.060 |
Why?
|
| Adolescent Behavior | 2 | 2007 | 193 | 0.060 |
Why?
|
| Metformin | 1 | 2006 | 73 | 0.060 |
Why?
|
| Manifest Anxiety Scale | 1 | 2004 | 2 | 0.060 |
Why?
|
| Patient Selection | 1 | 2007 | 488 | 0.060 |
Why?
|
| Endometrial Neoplasms | 3 | 2013 | 61 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2007 | 267 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2008 | 479 | 0.050 |
Why?
|
| Adolescent | 8 | 2007 | 6247 | 0.050 |
Why?
|
| Prognosis | 3 | 2017 | 1747 | 0.050 |
Why?
|
| Hypoglycemic Agents | 1 | 2006 | 219 | 0.050 |
Why?
|
| Personal Satisfaction | 2 | 2016 | 82 | 0.050 |
Why?
|
| Mental Recall | 1 | 2004 | 93 | 0.050 |
Why?
|
| Urban Health | 1 | 2003 | 40 | 0.050 |
Why?
|
| Secondary Prevention | 1 | 2004 | 163 | 0.050 |
Why?
|
| Health Benefit Plans, Employee | 1 | 2003 | 13 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2006 | 342 | 0.050 |
Why?
|
| Arteriosclerosis | 1 | 2002 | 30 | 0.050 |
Why?
|
| Mass Screening | 1 | 2008 | 690 | 0.050 |
Why?
|
| Behavior Therapy | 1 | 2004 | 167 | 0.050 |
Why?
|
| Food Services | 1 | 2002 | 24 | 0.050 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2002 | 49 | 0.050 |
Why?
|
| Brain | 1 | 2011 | 1553 | 0.050 |
Why?
|
| Waist Circumference | 2 | 2013 | 45 | 0.050 |
Why?
|
| Psychology, Adolescent | 1 | 2002 | 27 | 0.050 |
Why?
|
| Qualitative Research | 1 | 2006 | 684 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2016 | 614 | 0.050 |
Why?
|
| Recreation | 2 | 2016 | 21 | 0.050 |
Why?
|
| Gender Identity | 1 | 2002 | 67 | 0.050 |
Why?
|
| Reproducibility of Results | 4 | 2012 | 1650 | 0.050 |
Why?
|
| Drug Therapy, Combination | 2 | 2013 | 463 | 0.050 |
Why?
|
| Obstetrics | 1 | 2002 | 85 | 0.040 |
Why?
|
| Telephone | 2 | 2012 | 119 | 0.040 |
Why?
|
| Self Care | 1 | 2003 | 212 | 0.040 |
Why?
|
| Washington | 2 | 2013 | 26 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2005 | 435 | 0.040 |
Why?
|
| Physicians | 2 | 2005 | 470 | 0.040 |
Why?
|
| Pediatrics | 1 | 2002 | 254 | 0.040 |
Why?
|
| Quality Indicators, Health Care | 1 | 2003 | 337 | 0.040 |
Why?
|
| Blood Glucose | 2 | 2013 | 483 | 0.040 |
Why?
|
| Myocardial Revascularization | 2 | 2011 | 76 | 0.040 |
Why?
|
| Sleep Wake Disorders | 2 | 2015 | 72 | 0.040 |
Why?
|
| Contraceptive Agents, Female | 2 | 2009 | 24 | 0.040 |
Why?
|
| Feedback | 1 | 2018 | 93 | 0.040 |
Why?
|
| Lung | 1 | 2003 | 946 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2010 | 166 | 0.040 |
Why?
|
| Neoplasm Staging | 2 | 2010 | 501 | 0.040 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 35 | 0.030 |
Why?
|
| Mentors | 1 | 2018 | 119 | 0.030 |
Why?
|
| Sexual Partners | 1 | 2018 | 76 | 0.030 |
Why?
|
| Career Mobility | 1 | 2018 | 64 | 0.030 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2008 | 32 | 0.030 |
Why?
|
| Mental Health | 2 | 2015 | 371 | 0.030 |
Why?
|
| Fatty Acids | 2 | 2010 | 200 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 317 | 0.030 |
Why?
|
| Relaxation | 2 | 2007 | 6 | 0.030 |
Why?
|
| Interleukins | 1 | 2016 | 80 | 0.030 |
Why?
|
| Colonic Polyps | 2 | 2006 | 25 | 0.030 |
Why?
|
| Cancer Survivors | 1 | 2018 | 115 | 0.030 |
Why?
|
| Asthma | 1 | 2000 | 440 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 205 | 0.030 |
Why?
|
| Health Status Indicators | 1 | 2016 | 93 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2011 | 1082 | 0.030 |
Why?
|
| Respiratory Tract Diseases | 1 | 2015 | 37 | 0.030 |
Why?
|
| Powders | 1 | 2014 | 20 | 0.030 |
Why?
|
| Renal Insufficiency | 1 | 2015 | 66 | 0.030 |
Why?
|
| Observational Studies as Topic | 1 | 2014 | 59 | 0.030 |
Why?
|
| Thrombosis | 2 | 2009 | 199 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2015 | 6638 | 0.030 |
Why?
|
| Body Weights and Measures | 1 | 2013 | 33 | 0.030 |
Why?
|
| Body Height | 1 | 2013 | 68 | 0.030 |
Why?
|
| Control Groups | 1 | 2012 | 12 | 0.030 |
Why?
|
| Anticipation, Psychological | 1 | 2012 | 9 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2014 | 158 | 0.020 |
Why?
|
| Animals | 1 | 2011 | 20613 | 0.020 |
Why?
|
| Child | 3 | 2007 | 4531 | 0.020 |
Why?
|
| Geriatrics | 1 | 2013 | 43 | 0.020 |
Why?
|
| Neuropsychological Tests | 2 | 2006 | 392 | 0.020 |
Why?
|
| Focus Groups | 2 | 2004 | 303 | 0.020 |
Why?
|
| Professional-Patient Relations | 1 | 2012 | 128 | 0.020 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2012 | 47 | 0.020 |
Why?
|
| Angina Pectoris | 1 | 2011 | 38 | 0.020 |
Why?
|
| Reference Values | 1 | 2012 | 335 | 0.020 |
Why?
|
| Dominance, Cerebral | 1 | 2011 | 33 | 0.020 |
Why?
|
| Propensity Score | 1 | 2012 | 156 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2011 | 149 | 0.020 |
Why?
|
| Vitamin D Deficiency | 1 | 2011 | 43 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2012 | 202 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2014 | 378 | 0.020 |
Why?
|
| Psychometrics | 2 | 2004 | 376 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 2011 | 64 | 0.020 |
Why?
|
| Lipids | 1 | 2013 | 314 | 0.020 |
Why?
|
| Organ Size | 1 | 2011 | 172 | 0.020 |
Why?
|
| Placebos | 1 | 2010 | 72 | 0.020 |
Why?
|
| Carcinoma, Small Cell | 1 | 2010 | 22 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2010 | 86 | 0.020 |
Why?
|
| Ischemic Attack, Transient | 1 | 2011 | 96 | 0.020 |
Why?
|
| Nutrition Surveys | 1 | 2011 | 142 | 0.020 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2010 | 28 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 2010 | 73 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2013 | 410 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2013 | 753 | 0.020 |
Why?
|
| Insulin | 1 | 2013 | 685 | 0.020 |
Why?
|
| Rest | 1 | 2009 | 46 | 0.020 |
Why?
|
| Causality | 1 | 2009 | 58 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2009 | 66 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 421 | 0.020 |
Why?
|
| Bone Resorption | 1 | 2008 | 42 | 0.020 |
Why?
|
| Physical Fitness | 1 | 2008 | 92 | 0.020 |
Why?
|
| Feces | 1 | 2008 | 112 | 0.020 |
Why?
|
| Endoscopy | 1 | 2008 | 110 | 0.020 |
Why?
|
| Cotinine | 1 | 2007 | 19 | 0.020 |
Why?
|
| Exploratory Behavior | 1 | 2007 | 37 | 0.020 |
Why?
|
| Edible Grain | 1 | 2007 | 27 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2007 | 46 | 0.020 |
Why?
|
| Health Planning | 1 | 2007 | 32 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2007 | 165 | 0.020 |
Why?
|
| Saliva | 1 | 2007 | 103 | 0.020 |
Why?
|
| Vegetables | 1 | 2007 | 68 | 0.020 |
Why?
|
| Survival Rate | 1 | 2009 | 851 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2008 | 180 | 0.020 |
Why?
|
| Fruit | 1 | 2007 | 109 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2011 | 417 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2007 | 136 | 0.020 |
Why?
|
| Sudden Infant Death | 1 | 2006 | 24 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2007 | 201 | 0.020 |
Why?
|
| Medical Records | 1 | 2006 | 137 | 0.020 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2006 | 17 | 0.020 |
Why?
|
| Informed Consent | 1 | 2007 | 140 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2006 | 69 | 0.020 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2006 | 23 | 0.020 |
Why?
|
| Spinal Fractures | 1 | 2006 | 36 | 0.020 |
Why?
|
| Kidney Calculi | 1 | 2006 | 34 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2006 | 127 | 0.020 |
Why?
|
| Adenoma | 1 | 2006 | 69 | 0.020 |
Why?
|
| United States Dept. of Health and Human Services | 1 | 2005 | 7 | 0.010 |
Why?
|
| Interdisciplinary Communication | 1 | 2006 | 105 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2006 | 194 | 0.010 |
Why?
|
| Decision Making | 1 | 2009 | 407 | 0.010 |
Why?
|
| Publishing | 1 | 2006 | 93 | 0.010 |
Why?
|
| Memory | 1 | 2006 | 120 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 2005 | 104 | 0.010 |
Why?
|
| Review Literature as Topic | 1 | 2004 | 37 | 0.010 |
Why?
|
| Aspirin | 1 | 2006 | 171 | 0.010 |
Why?
|
| Dizziness | 1 | 2004 | 18 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2004 | 106 | 0.010 |
Why?
|
| Forecasting | 1 | 2004 | 232 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2005 | 268 | 0.010 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2003 | 62 | 0.010 |
Why?
|
| Nausea | 1 | 2004 | 111 | 0.010 |
Why?
|
| Progesterone | 1 | 2004 | 163 | 0.010 |
Why?
|
| Forced Expiratory Volume | 1 | 2003 | 201 | 0.010 |
Why?
|
| Clinical Trials Data Monitoring Committees | 1 | 2002 | 4 | 0.010 |
Why?
|
| Registries | 1 | 2006 | 887 | 0.010 |
Why?
|
| Sunlight | 1 | 2002 | 30 | 0.010 |
Why?
|
| Internal-External Control | 1 | 2002 | 33 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2006 | 1356 | 0.010 |
Why?
|
| Cholesterol | 1 | 2003 | 259 | 0.010 |
Why?
|
| Physical Examination | 1 | 2002 | 112 | 0.010 |
Why?
|
| Factor Analysis, Statistical | 1 | 2002 | 97 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 1542 | 0.010 |
Why?
|
| Family | 1 | 2003 | 238 | 0.010 |
Why?
|
| Hospitalization | 1 | 2008 | 1359 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2007 | 1616 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2002 | 519 | 0.010 |
Why?
|